November 9, 2023 02:41 PM ESTUpdated 05:04 PM
Pharma
Marketing

Ot­su­ka TV and ban­ner ads for Rex­ul­ti draw re­buke from FDA watch­dog

Beth Snyder Bulik

Senior Editor

Ot­su­ka is the lat­est phar­ma in a week to re­ceive a vi­o­la­tion let­ter from FDA’s drug pro­mo­tion po­lice. Its Rex­ul­ti TV com­mer­cial and a ban­ner …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

As­traZeneca Chi­na ex­ec probed by lo­cal au­thor­i­ties

Up­dat­ed: Lil­ly’s shares tank af­ter trim­ming rev­enue guid­ance. It al­so cut three as­sets

Bio­phar­ma be­gins to con­tem­plate an RFK Jr.-in­flu­enced FDA if Trump wins

A start­up backed by No­bel win­ner David Bak­er takes an AI twist on an­ti­bod­ies

At­las of tu­mors re­veals in 3D how cells change in­to can­cer

Lund­beck dou­bled its of­fer for Long­board over six months, new fil­ing shows

A service from the Financial Times